Esperion Therapeutics Inc... (ESPR)
NASDAQ: ESPR
· Real-Time Price · USD
1.04
-0.03 (-2.80%)
At close: Jun 23, 2025, 3:59 PM
1.01
-2.88%
Pre-market: Jun 24, 2025, 05:19 AM EDT
Esperion Therapeutics Revenue
Esperion Therapeutics reported an annual revenue of $332.31M, reflecting a 185.66% growth. For the quarter ending March 31, 2025, Esperion Therapeutics generated $65M in revenue.
Revenue (ttm)
$332.31M
Revenue Growth
185.66%
Price / Sales Ratio
1.24
Revenue / Employee
$1.09M
Employees
304
Market Cap
206.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|